Search Results

You are looking at 141 - 150 of 204 items for :

  • "lymph node dissection" x
  • Refine by Access: All x
Clear All
Full access

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Sam Chang, Tracy M. Downs, Jason A. Efstathiou, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Thomas Guzzo, Harry W. Herr, Jean Hoffman-Censits, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Jeff Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker-Radtke, Jonathan Tward, Jonathan L. Wright, Lisa A. Gurski, and Alyse Johnson-Chilla

surgery (biopsy or TURBT), and imaging studies. A modifier “p” would refer to pathologic staging based on cystectomy and lymph node dissection. Pathology and Staging The most commonly used staging system is the tumor, node, metastasis (TNM) staging system

Full access

Derek J. Erstad, Mariela Blum, Jeannelyn S. Estrella, Prajnan Das, Bruce D. Minsky, Jaffer A. Ajani, Paul F. Mansfield, Naruhiko Ikoma, and Brian D. Badgwell

; 11 : 439 – 449 . 20409751 10.1016/S1470-2045(10)70070-X 6. Seevaratnam R , Bocicariu A , Cardoso R , A meta-analysis of D1 versus D2 lymph node dissection . Gastric Cancer 2012 ; 15 ( Suppl 1 ): S60 – 69 . 10.1007/s10120

Full access

C. Anthony Blau, Arturo B. Ramirez, Sibel Blau, Colin C. Pritchard, Michael O. Dorschner, Stephen C. Schmechel, Timothy J. Martins, Elisabeth M. Mahen, Kimberly A. Burton, Vitalina M. Komashko, Amie J. Radenbaugh, Katy Dougherty, Anju Thomas, Christopher P. Miller, James Annis, Jonathan R. Fromm, Chaozhong Song, Elizabeth Chang, Kellie Howard, Sharon Austin, Rodney A. Schmidt, Michael L. Linenberger, Pamela S. Becker, Francis M. Senecal, Brigham H. Mecham, Su-In Lee, Anup Madan, Roy Ronen, Janusz Dutkowski, Shelly Heimfeld, Brent L. Wood, Jackie L. Stilwell, Eric P. Kaldjian, David Haussler, and Jingchun Zhu

following month she underwent a right mastectomy with axillary lymph node dissection. Pathology revealed a 5.5-cm infiltrating carcinoma with lobular features, lymphovascular invasion with negative margins, and metastatic involvement in 20 of 25 lymph nodes

Full access

David J. Worhunsky, Yifei Ma, Yulia Zak, George A. Poultsides, Jeffrey A. Norton, Kim F. Rhoads, and Brendan C. Visser

Although multiple quality indicators have been studied for the management of gastric cancer, notably surgical technique and the extent of lymph node dissection, 12 – 14 limited data exist regarding implementation and effectiveness of clinical guidelines

Full access

Fei Gao, Nan Li, YongMei Xu, and GuoWang Yang

prone to local recurrence and distant metastasis after surgery. 2 Multidisciplinary sequential therapy is applied in patients with stage IIIA NSCLC. Complete surgical resection of the primary lesion and mediastinal lymph node dissection are recommended

Full access

Linda A. Jacobs and David J. Vaughn

the most commonly used treatment regimens. At the completion of treatment, an assessment of response and the need for postchemotherapy surgery (e.g., a retroperitoneal lymph node dissection [RPLND]) is assessed. Radiation therapy is another treatment

Full access

Lyndsay J. Willmott, Daniele A. Sumner, and Bradley J. Monk

treatment protocol is surgical resection, typically with radical hysterectomy and pelvic lymph node dissection. Cure rates are good in this instance. However, more advanced disease is a greater challenge to treat effectively. The American Cancer Society

Full access

Christopher J. Long, Sameer Mittal, and Thomas F. Kolon

. Another technical concern regarding PN that is not present with RN is the role of surgical margins. It is imperative that intraoperative margins are negative from the tumor resection bed. A lymph node dissection is imperative, as with any approach to tumor

Full access

Mathias Kvist Mejdahl, Birgitte Goldschmidt Mertz, Pernille Envold Bidstrup, and Kenneth Geving Andersen

, 35 receiving surgery with mastectomy or breast-conserving surgery (BCS), and sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) of levels I through II. Adjuvant treatment was according to risk profile, with chemotherapy

Full access

Thanh H. Dellinger, Amy A. Hakim, Stephen J. Lee, Mark T. Wakabayashi, Robert J. Morgan, and Ernest S. Han

JL . A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study . Gynecol Oncol 2008 ; 110 : 76 – 82 . 27. Van der Zee AG Oonk MH De Hullu JA